Informações:
Falhas:
ID
34354
Descrição
Withdrawal of Etanercept After Successful Treatment of Juvenile Idiopathic Arthritis; ODM derived from: https://clinicaltrials.gov/show/NCT01287715
Link
https://clinicaltrials.gov/show/NCT01287715
Palavras-chave
Versões (1)
- 16/01/2019 16/01/2019 -
Titular dos direitos
see on clinicaltrials.gov
Transferido a
16 de janeiro de 2019
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Juvenile Idiopathic Arthritis NCT01287715
Eligibility Juvenile Idiopathic Arthritis NCT01287715
- StudyEvent: Eligibility
Similar models
Eligibility Juvenile Idiopathic Arthritis NCT01287715
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
ID.1
Item
diagnosis of juvenile idiopathic arthritis (all subtypes) by the international league of associations of rheumatology (ilar) criteria
boolean
ID.2
Item
on etanercept therapy
boolean
ID.3
Item
no mtx or low dose mtx (maximum 10 mg/m2)
boolean
ID.4
Item
3 or more months in remission according to the criteria of wallace (i.e. 9 or more months of inactive disease)
boolean
ID.5
Item
age ≥4 and <18 years at start of study
boolean
ID.6
Item
written informed consent from parents and patients 12 years and over
boolean
ID.7
Item
systemic corticosteroids (up to 9 months prior to inclusion)
boolean
ID.8
Item
intra-articular corticosteroids (up to 6 months prior to inclusion)
boolean
ID.9
Item
synthetic dmards besides low dose mtx (up to 9 months prior to inclusion)
boolean
ID.10
Item
biologic dmards besides etanercept (up to 9 months prior to inclusion)
boolean